Journal of Substance Abuse Treatment
Volume 31, Issue 4 , Pages 433-438 , December 2006

A 5-year evaluation of a methadone medical maintenance program

  • Kenneth A. Harris Jr, M.D., Ph.D.

      Affiliations

    • Division of Substance Abuse, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA
    • Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA
    • Corresponding Author InformationCorresponding author. Van Etten Clinic, Albert Einstein College of Medicine, 1500 Waters Place, Bronx, NY 10461, USA. Tel.: +1 718 829 3440; fax: +1 718 918 9461.
    • ,
  • Julia H. Arnsten, M.D., M.P.H.

      Affiliations

    • Division of Substance Abuse, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA
    • Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA
    • ,
  • Herman Joseph, Ph.D.

      Affiliations

    • Rockefeller University, New York, NY, USA
    • ,
  • Joe Hecht, R.Ph.

      Affiliations

    • Division of Substance Abuse, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA
    • ,
  • Ira Marion, M.A.

      Affiliations

    • Division of Substance Abuse, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA
    • ,
  • Patti Juliana, M.S.W.

      Affiliations

    • Methadone Maintenance Treatment Program, Beth Israel Medical Center, New York, NY, USA
    • ,
  • Marc N. Gourevitch, M.D., M.P.H.

      Affiliations

    • Division of General Internal Medicine, Department of Medicine, New York University School of Medicine, New York, NY

Received 14 November 2005 ,Revised 24 May 2006 ,Accepted 24 May 2006.

References 

  1. Anglin MD, Speckart GR, Booth MW, Ryan TM. Consequences and costs of shutting off methadone. Addictive Behaviors. 1989;14:307–326
  2. Ball J, Ross A. The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcomes. New York: Springer-Verlag; 1991;
  3. Barnett PG, Hui SS. The cost-effectiveness of methadone maintenance. Mount Sinai Journal of Medicine. 2000;67:365–374
  4. Barnett PG, Rodgers JH, Bloch DA. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction. 2001;96:683–690
  5. Byrne A, Wodak A. Census of patients receiving methadone treatment in a general practice. Addiction Research. 1996;3:341–349
  6. DesJarlais DC, Joseph H, Dole VP, Nyswander ME. Medical maintenance feasibility study. NIDA Research Monographs. 1985;58:101–110
  7. Dole VP, Joseph H. Long-term outcome of patients treated with methadone maintenance. Annals of the New York Academy of Sciences. 1978;311:181–189
  8. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. Journal of the American Medical Association. 1965;193:646–650
  9. Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction. 2005;100:1496–1509
  10. Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews. 2003;(3):(Art. No. CD002208)
  11. Fiellin DA, Barthwell AG. Guideline development for office-based pharmacotherapies for opioid dependence. Journal of Addictive Diseases. 2003;22:109–120
  12. Fiellin DA, O'Connor PG. New federal initiatives to enhance the medical treatment of opioid dependence. Annals of Internal Medicine. 2002;137:688–692
  13. Fiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone maintenance in primary care: A randomized controlled trial. Journal of the American Medical Association. 2001;286:1724–1731
  14. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health. 1996;86:655–661
  15. Joseph, H., 1995. Methadone medical maintenance: The further concealment of a stigmatized condition (PhD dissertation). New York City: University of New York.
  16. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mount Sinai Journal of Medicine. 2000;67:347–364
  17. King VL, Stoller KB, Hayes M, Umbricht A, Currens M, Kidorf MS, et al. A multicenter randomized evaluation of methadone medical maintenance. Drug and Alcohol Dependence. 2002;65:137–148
  18. Luger L, Bathia N, Alcorn R, Power R. Involvement of community pharmacists in the care of drug misusers: Pharmacy-based supervision of methadone consumption. International Journal of Drug Policy. 2000;11:227–234
  19. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews. 2003;(2):(Art. No. CD002209)
  20. Merrill JO, Jackson TR, Schulman BA, Saxon AJ, Awan A, Kapitan S, et al. Methadone medical maintenance in primary care: An implementation evaluation. Journal of General Internal Medicine. 2005;20:344–349
  21. Murphy S, Irwin J. “Living with the dirty secret”: Problems of disclosure for methadone maintenance clients. Journal of Psychoactive Drugs. 1992;24:257–264
  22. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction . Effective medical treatment of opiate addiction. Journal of the American Medical Association. 1998;280:1936–1943
  23. Novick DM, Joseph H, Croxson TS, Salsitz EA, Wang G, Richman BL, et al. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine. 1990;150:97–99
  24. Novick DM, Joseph H, Salsitz EA, Kalin MF, Keefe JB, Miller EL, et al. Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance): Follow-up at three and a half to nine and a fourth years. Journal of General Internal Medicine. 1994;9:127–130
  25. Novick DM, Pascarelli EF, Joseph H, Salsitz EA, Richman BL, Des J, et al. Methadone maintenance patients in general medical practice. A preliminary report. Journal of the American Medical Association. 1988;259:3299–3302
  26. O'Connor PG, Oliveto AH, Shi JM, Triffleman E, Carroll KM, Kosten TR, et al. A pilot study of primary-care-based buprenorphine maintenance for heroin dependence. American Journal of Drug and Alcohol Abuse. 1996;22:523–531
  27. O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine. 1998;105:100–105
  28. Salsitz EA, Joseph H, Frank B, Perez J, Richman BL, Salomon N, et al. Methadone medical maintenance (MMM): Treating chronic opioid dependence in private medical practice—A summary report (1983–1998). Mount Sinai Journal of Medicine. 2000;67:388–397
  29. Schwartz RP, Brooner RK, Montoya ID, Currens M, Hayes M. A 12-year follow-up of a methadone medical maintenance program. American Journal of Addiction. 1999;8:293–299
  30. Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. Journal of the American Medical Association. 2000;283:1303–1310
  31. Senay EC, Barthwell A, Marks R, Bokos P, Gillman D, White R. Medical maintenance: A pilot study. Journal of Addictive Diseases. 1993;12:59–76
  32. Senay EC, Barthwell A, Marks R, Bokos PJ. Medical maintenance: An interim report. Journal of Addictive Diseases. 1994;13:65–69
  33. Simoens S, Matheson C, Bond C, Inkster K, Ludbrook A. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. British Journal of General Practice. 2005;55:139–146
  34. Simpson DD, Joe GW, Rowan-Szal G, Greener J. Client engagement and change during drug abuse treatment. Journal of Substance Abuse. 1995;7:117–134
  35. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence: A randomized trial. Journal of the American Medical Association. 1999;281:1000–1005
  36. Strang J, Sheridan J, Hunt C, Kerr B, Gerada C, Pringle M. The prescribing of methadone and other opioids to addicts: National survey of GPs in England and Wales. British Journal of General Practice. 2005;55:444–451
  37. U.S. Census Bureau, Housing and Household Economics Division, Small Areas Estimates Branch . Small area income and poverty estimates. Available at: http://www.census.gov/hhes/www/saipe/county.html2004;
  38. Whitley SD, Arnsten JH, Gourevitch MN. Co-locating buprenorphine and methadone maintenance treatment: Challenges and opportunities. In: Abstract, American Association for the Treatment of Opioid Dependence Conference 2004, Orlando, FL, October, 2004. 2004;

PII: S0740-5472(06)00160-7

doi: 10.1016/j.jsat.2006.05.018

Journal of Substance Abuse Treatment
Volume 31, Issue 4 , Pages 433-438 , December 2006

Article Tools